Top Stories

Carbonxt Group Releases Its December 2022 Quarterly Report

Carbonxt Group Releases Its December 2022 Quarterly Report

Carbonxt Group LTD (ASX: CG1) (“Carbonxt” or the “Company”) has released its December 2022 quarterly report highlighting the key activities of the Company. R&D and Industry Activities Carbonxt’s research and development team completed a program focusing on ‘the effects of heat treatment on Activated Carbon’ with the help of a renowned R&D service company. The …

Carbonxt Group Releases Its December 2022 Quarterly Report Read More »

Eclipse Metals Reports a Busy December 2022 Quarter

Eclipse Metals Reports a Busy December 2022 Quarter

Eclipse Metals (ASX: EPM and FSE: 9EU) (Eclipse or the Company) has released its quarterly report highlighting the project advancements and other activities during the December 2022 quarter. Here are the updates on the activities carried out by Eclipse. GREENLAND PROJECT Multi-commodity Greenland Project Updates Eclipse Metals has completed the maiden percussion drilling and trench …

Eclipse Metals Reports a Busy December 2022 Quarter Read More »

Worlds Best Restaurant Noma, What Is All the Buzz About

World’s Best Restaurant Noma: What Is All the Buzz About?

Unless you have been living under a rock, you have heard of the Noma Restaurant at least once. Winning multiple awards as the World’s Best Restaurant, Noma has come a long way since its inception in 2003. Noma’s Magical Ambiance Claus Meyer and Rene Redzepi started the Noma Restaurant in Copenhagen, Denmark, guided by the …

World’s Best Restaurant Noma: What Is All the Buzz About? Read More »

Roquefort Therapeutics Reports In-Vivo Safety for Midkine Oncology Antibodies

Roquefort Therapeutics Reports In-Vivo Safety for Midkine Oncology Antibodies

Roquefort Therapeutics (LSE: ROQ, OTCQB: ROQAF) (“Roquefort” or the “Company”) announces that two of its Midkine (MDK) antibody programs, ROQ-A1 and ROQ-A2, demonstrate in-vivo safety in the pre-clinical development programs. The pre-clinical programs were carried out by leading cancer research groups. ROQ-A1 and ROQ-A2 are two patented antibody medicines designed by Roquefort to target metastatic breast …

Roquefort Therapeutics Reports In-Vivo Safety for Midkine Oncology Antibodies Read More »

Dark Chocolate More Than Just A Luxurious Treat

Dark Chocolate: More Than Just A Luxurious Treat?

Ah, chocolate! Willy Wonka’s favourite confection! It’s a treat that has been around for centuries but has recently surged in popularity. Dark chocolate, in particular, has caught the attention of health-conscious consumers. However, have you never wondered what exactly dark chocolate is and why is dark chocolate good for you? So grab your Golden Ticket, …

Dark Chocolate: More Than Just A Luxurious Treat? Read More »